These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12705994)

  • 1. Second transurethral resection and adjuvant radiotherapy in conservative treatment of pT2N0M0 bladder tumors.
    Geavlete P; Georgescu D; Florea I
    Eur Urol; 2003 May; 43(5):499-504. PubMed ID: 12705994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma].
    Vögeli TA; Grimm MO; Simon X; Ackermann R
    Urologe A; 2002 Sep; 41(5):470-4. PubMed ID: 12426865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
    Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
    J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer.
    Guigui A; Basile G; Zattoni F; Gallioli A; Verri P; Aumatell J; Gondran-Tellier B; Lechevallier E; Bastide C; Uleri A; Sica M; Long-Depaquit T; Dinoi G; Moro FD; Akiki A; Toledano H; Rajwa P; Montorsi F; Amparore D; Porpiglia F; Breda A; Moschini M; Baboudjian M
    World J Urol; 2024 Aug; 42(1):480. PubMed ID: 39133324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
    Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
    Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
    Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience.
    de Crevoisier R; Ammor A; Court B; Wibault P; Chirat E; Fizazi K; Theodore C; Yom SS; Haie-Meder C
    Radiother Oncol; 2004 Aug; 72(2):147-57. PubMed ID: 15376367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcome after laparoscopic radical cystectomy without neoadjuvant or adjuvant therapy with a median follow-up of 32 months.
    Hermans TJ; Fossion LM
    Urol Int; 2014; 92(1):55-63. PubMed ID: 24061529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.
    Rödel C; Grabenbauer GG; Kühn R; Papadopoulos T; Dunst J; Meyer M; Schrott KM; Sauer R
    J Clin Oncol; 2002 Jul; 20(14):3061-71. PubMed ID: 12118019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Naselli A; Hurle R; Paparella S; Buffi NM; Lughezzani G; Lista G; Casale P; Saita A; Lazzeri M; Guazzoni G
    Eur Urol Focus; 2018 Jul; 4(4):558-567. PubMed ID: 28753839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
    Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
    Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.
    Zaghloul MS; Nouh A; Nazmy M; Ramzy S; Zaghloul AS; Sedira MA; Khalil E
    Urol Oncol; 2006; 24(1):13-20. PubMed ID: 16414487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.